bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: April 5, 2023
Abstract
Germinal
centre
(GC)
B
cells
proliferate
at
some
of
the
highest
rates
any
mammalian
cell,
yet
metabolic
processes
which
enable
this
are
poorly
understood.
We
performed
integrated
metabolomic
and
transcriptomic
profiling
GC
cells,
found
that
metabolism
non-essential
amino
acid
asparagine
(Asn)
was
highly
upregulated.
Asn
conditionally
essential
to
its
synthetic
enzyme,
synthetase
(ASNS)
upregulated
following
their
activation,
particularly
more
markedly
in
absence
Asn,
through
stress
response
sensor
general
control
non-derepressible
2
(GCN2).
When
Asns
is
deleted
cell
survival
proliferation
low
conditions
were
strongly
impaired,
removal
environmental
by
asparaginase
or
dietary
restriction
compromised
reaction,
impairing
affinity
maturation
humoral
influenza
infection.
Using
stable
isotope
tracing
single
RNA
sequencing,
we
adaptation
requires
ASNS,
oxidative
phosphorylation,
mitochondrial
homeostasis,
synthesis
nucleotides
sensitive
deprivation.
Altogether,
reveal
acts
as
a
key
regulator
function
homeostasis.
The
one
sentence
summary
Asparagine
critical
function,
maintaining
germinal
reaction.
Journal of Hematology & Oncology,
Journal Year:
2023,
Volume and Issue:
16(1)
Published: Aug. 24, 2023
Abstract
Cancers
are
a
group
of
heterogeneous
diseases
characterized
by
the
acquisition
functional
capabilities
during
transition
from
normal
to
neoplastic
state.
Powerful
experimental
and
computational
tools
can
be
applied
elucidate
mechanisms
occurrence,
progression,
metastasis,
drug
resistance;
however,
challenges
remain.
Bulk
RNA
sequencing
techniques
only
reflect
average
gene
expression
in
sample,
making
it
difficult
understand
tumor
heterogeneity
microenvironment.
The
emergence
development
single-cell
(scRNA-seq)
technologies
have
provided
opportunities
subtle
changes
biology
identifying
distinct
cell
subpopulations,
dissecting
microenvironment,
characterizing
cellular
genomic
mutations.
Recently,
scRNA-seq
technology
has
been
increasingly
used
cancer
studies
explore
which
increased
understanding
tumorigenesis
evolution.
This
review
summarizes
basic
processes
their
increasing
applications
research
clinical
practice.
Nature Metabolism,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 5, 2025
Preclinical
studies
have
shown
that
asparagine
deprivation
enhances
T
cell
antitumour
responses.
Here
we
apply
compassionate
use
of
L-asparaginase,
usually
employed
to
treat
blood
malignancies,
on
patients
with
recurrent
metastatic
nasopharyngeal
carcinoma.
The
L-asparaginase
notably
immune-checkpoint
blockade
therapy
in
by
strengthening
CD8+T
fitness.
Our
study
shows
this
combination
is
a
promising
avenue
for
clinical
application
and
provides
further
mechanistic
insight
into
how
restriction
rewires
metabolism.
Cell,
Journal Year:
2023,
Volume and Issue:
186(25), P. 5620 - 5637.e16
Published: Dec. 1, 2023
Colorectal
cancer
exhibits
dynamic
cellular
and
genetic
heterogeneity
during
progression
from
precursor
lesions
toward
malignancy.
Analysis
of
spatial
multi-omic
data
31
human
colorectal
specimens
enabled
phylogeographic
mapping
tumor
evolution
that
revealed
individualized
trajectories
accompanying
microenvironmental
clonal
alterations.
Phylogeographic
ordered
events,
classified
tumors
by
their
evolutionary
dynamics,
placed
regions
along
global
pseudotemporal
encompassing
the
chromosomal
instability
(CIN+)
hypermutated
(HM)
pathways.
Integrated
single-cell
transcriptomic
recurring
epithelial
programs
infiltrating
immune
states
pseudotime.
We
discovered
an
exclusion
signature
(IEX),
consisting
extracellular
matrix
regulators
DDR1,
TGFBI,
PAK4,
DPEP1,
charts
with
CIN+
progression,
is
associated
reduced
cytotoxic
cell
infiltration,
shows
prognostic
value
in
independent
cohorts.
This
atlas
provides
insights
into
tumor-microenvironment
co-evolution,
serving
as
a
resource
for
stratification
targeted
treatments.
Cell Reports,
Journal Year:
2024,
Volume and Issue:
43(4), P. 113995 - 113995
Published: March 23, 2024
The
tumor
microenvironment
(TME)
is
restricted
in
metabolic
nutrients
including
the
semi-essential
amino
acid
arginine.
While
complete
arginine
deprivation
causes
T
cell
dysfunction,
it
remains
unclear
how
levels
fluctuate
TME
to
shape
fates.
Here,
we
find
that
20-μM
low
condition,
representing
found
plasma
of
patients
with
cancers,
confers
Treg-like
immunosuppressive
capacities
upon
activated
cells.
In
vivo
mouse
models
and
human
single-cell
RNA-sequencing
datasets
reveal
positive
correlations
between
condition
intratumoral
Treg
accumulation.
Mechanistically,
arginine-activated
cells
engage
transcriptional
reprogramming,
using
ATF4-SLC7A11-GSH
axis,
preserve
their
suppressive
function.
These
findings
improve
our
understanding
role
biology
potential
applications
for
immunotherapy
strategies.
Trends in Molecular Medicine,
Journal Year:
2024,
Volume and Issue:
30(6), P. 592 - 604
Published: April 10, 2024
Pancreatic
ductal
adenocarcinoma
(PDAC)
is
a
highly
aggressive
form
of
pancreatic
cancer,
known
for
its
challenging
diagnosis
and
limited
treatment
options.
The
focus
on
metabolic
reprogramming
as
key
factor
in
tumor
initiation,
progression,
therapy
resistance
has
gained
prominence.
In
this
review
we
the
impact
changes
interplay
among
stromal,
immune,
cells,
glutamine
branched-chain
amino
acids
(BCAAs)
emerge
pivotal
players
modulating
immune
cell
functions
growth.
We
also
discuss
ongoing
clinical
trials
that
explore
modulation
PDAC,
targeting
mitochondrial
metabolism,
asparagine
addiction,
autophagy
inhibition.
Overcoming
challenges
understanding
nutrient
effects
immune-stromal-tumor
interactions
holds
promise
innovative
therapeutic
strategies.
Molecular Cancer,
Journal Year:
2023,
Volume and Issue:
22(1)
Published: July 15, 2023
Abstract
The
diagnosis
of
brain
metastasis
(BrM)
has
historically
been
a
dooming
that
is
nothing
less
than
death
sentence,
with
few
treatment
options
for
palliation
or
prolonging
life.
Among
the
available,
radiotherapy
(RT)
and
surgical
resection
have
backbone
therapy.
Within
past
couple
years,
immunotherapy
(IT),
alone
in
combination
traditional
treatments,
emerged
as
reckoning
force
to
combat
spread
BrM
shrink
tumor
burden.
This
review
compiles
recent
reports
describing
potential
role
IT
various
cancers.
It
also
examines
impact
microenvironment
on
regulating
cancer
can
play
mitigating
spread.
Lastly,
this
focuses
future
new
clinical
trials
pushing
boundaries
BrM.
Clinical and Translational Medicine,
Journal Year:
2024,
Volume and Issue:
14(3)
Published: March 1, 2024
Abstract
As
single‐cell
RNA
sequencing
enables
the
detailed
clustering
of
T‐cell
subpopulations
and
facilitates
analysis
metabolic
states
metabolite
dynamics,
it
has
gained
prominence
as
preferred
tool
for
understanding
heterogeneous
cellular
metabolism.
Furthermore,
synergistic
or
inhibitory
effects
various
pathways
within
T
cells
in
tumour
microenvironment
are
coordinated,
increased
activity
specific
generally
corresponds
to
functional
activity,
leading
diverse
behaviours
related
immune
cells,
which
shows
potential
tumour‐specific
induce
persistent
responses.
A
holistic
how
heterogeneity
governs
function
subsets
is
key
obtaining
field‐level
insights
into
immunometabolism.
Therefore,
exploring
mechanisms
underlying
interplay
between
metabolism
functions
will
pave
way
precise
immunotherapy
approaches
future,
empower
us
explore
new
methods
combating
tumours
with
enhanced
efficacy.
The Journal of Experimental Medicine,
Journal Year:
2025,
Volume and Issue:
222(6)
Published: April 11, 2025
The
tumor–immune
microenvironment
(TIME)
plays
a
critical
role
in
tumor
development
and
metastasis,
as
it
influences
the
evolution
of
cells
fosters
an
immunosuppressive
state
by
intervening
metabolic
reprogramming
infiltrating
immune
cells.
Aging
diet
significantly
impact
TIME,
contributing
to
cancer
progression
evasion.
With
aging,
cell
function
declines,
leading
proinflammatory
alterations
such
increased
oxidative
stress
mitochondrial
dysfunction,
which
compromise
antitumor
immunity.
Similarly,
dietary
factors,
particularly
high-fat
high-sugar
diets,
promote
shifts,
creating
permissive
TIME
fostering
tumor-supportive
phenotypes
while
impairing
tumoricidal
activity
In
contrast,
restrictions
have
been
shown
restore
modulating
metabolism
enhancing
responses.
Here,
we
discuss
intricate
interplay
between
diet,
shaping
with
particular
focus
on
T
cells,
highlight
therapeutic
strategies
targeting
these
pathways
empower